CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CorWave is developing a novel left ventricular assist device (LVAD) that mimics natural blood flow to improve the quality of life for advanced heart failure patients. This innovative pump aims to reduce complications and hospital readmissions significantly.
Advanced heart failure (HF) is a deadly disease, with a booming incidence driven by durable socio-demographic trends.
Left ventricular assist devices (LVADs) are a life-saving therapy for advanced HF patients and represent a billion-euro market.
However, only 13% of the 60,000 eligible patients are implanted with current LVADs each year, due to the extremely high rate of severe adverse events (stroke, bleeding, infection) and the limited quality of life.CorWave is an innovative French SME create…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
